ATOS: Atossa Therapeutics Inc

ATOS新闻

• 16:05 France stocks lower at close of trade; CAC 40 down 1.59%
• 16:05 France stocks lower at close of trade; CAC 40 down 0.44%
• 16:05 France stocks higher at close of trade; CAC 40 up 1.21%
• 16:05 France stocks higher at close of trade; CAC 40 up 0.84%
• 16:05 France stocks higher at close of trade; CAC 40 up 0.66%
• 16:05 France stocks higher at close of trade; CAC 40 up 0.44%
• 16:05 France stocks higher at close of trade; CAC 40 up 0.18%
• 16:05 France stocks higher at close of trade; CAC 40 up 1.14%
• 16:05 France stocks lower at close of trade; CAC 40 down 2.91%
• 07:07 European stocks fall on more trade turmoil; eurozone CPI, U.S. payrolls in focus
• 06:31 Atos posts H1 drop in orders and revenue on weak demand, tough market backdrop
• 13:29 Atossa Therapeutics stock jumps after FDA provides positive feedback
• 11:51 Atossa receives FDA feedback for breast cancer drug development
• 09:19 Atos shares climb 4% after reporting stronger half-year liquidity position
• 16:05 France stocks higher at close of trade; CAC 40 up 1.44%
• 12:14 Atossa Genetics Year-end 2024 slides: (Z)-endoxifen shows promise, expenses decline
• 08:30 BofA assesses the impact of foreign tax in budget bill on European software names
• 16:05 France stocks lower at close of trade; CAC 40 down 1.34%
• 10:12 Ascendiant Capital raises Atossa Genetics stock price target to $7.50
• 19:17 This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Excelerate Energy (NYSE:EE), Atossa Therapeutics (NASDAQ:ATOS)
• 13:30 Craig-Hallum initiates Atossa Genetics stock with buy rating
• 16:05 France stocks higher at close of trade; CAC 40 up 0.34%
• 12:56 Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference
• 05:45 French government confirms $466.33 million offer for Atos’ former business